Based in the United States, VIVUS is a startup. Brouky records 1 investor associated with the company.
VIVUS is a biopharmaceutical company focused on the clinical development and commercialization of innovative therapies to address serious medical conditions and improve patient quality of life globally.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.